Brief: Vertex And Ono Pharmaceutical Announce Strategic Agreement To Develop & Commercialize Povetacicept In Japan & South Korea
23/06/2025 10:39
June 23 (Reuters) - Vertex Pharmaceuticals: VERTEX AND ONO PHARMACEUTICAL ANNOUNCE STRATEGIC AGREEMENT TO DEVELOP AND COMMERCIALIZE POVETACICEPT IN JAPAN AND SOUTH KOREA VERTEX PHARMACEUTICALS: WILL RECEIVE AN UPFRONT PAYMENT, AS WELL AS CERTAIN REGULATORY AND COMMERCIAL MILESTONE PAYMENTS AND TIERED ROYALTIES Source text: ID:nBwm1mnca Further company coverage: 4528.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vertex Pharmaceuticals Incorporated
See all newsBrief: Vertex Appoints Daniel Brennan To Its Board Of Directors
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Vertex rises after kidney disease drug shows promise in mid-stage study
Brief: Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR By -42.7% At Week 13 In AMKD With Modest Proteinuria